Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PRQR will decline by -10.91% over the next 2 Weeks and hit $1.37 by Wednesday, March 11, 2026. In that time frame, PRQR's share price is expected to range between $1.24 and $1.50.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 11, 2026 | 1.24 | 1.37 | 1.50 |
| Mar 10, 2026 | 1.25 | 1.38 | 1.51 |
| Mar 9, 2026 | 1.24 | 1.36 | 1.49 |
| Mar 6, 2026 | 1.27 | 1.40 | 1.52 |
| Mar 5, 2026 | 1.29 | 1.41 | 1.55 |
| Mar 4, 2026 | 1.32 | 1.45 | 1.58 |
| Mar 3, 2026 | 1.32 | 1.45 | 1.58 |
| Mar 2, 2026 | 1.31 | 1.44 | 1.58 |
| Feb 27, 2026 | 1.34 | 1.47 | 1.60 |
| Feb 26, 2026 | 1.36 | 1.49 | 1.62 |
PRQR shares rose +1.99% in Wednesday, February 25, 2026's trading session, rising from a previous close of $1.51 to move at $1.54. The stock demonstrated notable intraday movement (see PRQR's key stats for a full breakdown), fluctuating between $1.50 and $1.58, a +5.35% trading range. While recent weeks have seen some volatility, PRQR has managed to secure a +8.45% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 166.23K shares changing hands, 105.97K fewer than the previous session. This amounted to $256.00K in total market activity.
Will PRQR Continue Its Downward Trend?
According to analyst ratings and projections for PRQR, ProQR Therapeutics N.V. shares are anticipated to decrease by -2.87%, potentially reaching $1.50 per share by March 11, 2026. Short-term technical indicators currently suggest a neutral sentiment for PRQR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the PRQR stock forecast, now is not the best time to buy PRQR stock because its current trading price is +12.24% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on PRQR covering social and institutional perspectives.
PRQR Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PRQR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.79% to 54.43%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 44.23%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.54%, maintains a neutral outlook for the long term. Insights into PRQR's shareholder base show how institutional investors are positioning themselves during these momentum shifts
ProQR Therapeutics NV Short-Term Forecasts
PRQR Forecast For Next 5 Days
Our algorithm anticipates ProQR Therapeutics NV (PRQR) stock could hit $1.27 by Mar 04, 2026. This represents a -17.72% fall from today's price, following a 0 change over the past five days.
PRQR Forecast For Next 30 Days
Based on analysis of market trends, the outlook for ProQR Therapeutics N.V. (PRQR) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.17, which would mean a -24.03% decrease from the current price of $1.54. Projections for this period range from a high of $1.58 to a low of $0.81.
PRQR Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for ProQR Therapeutics NV's price over the next three months point to a rise. PRQR stock is expected to peak at $8.31 on Feb 26, 2026 before potentially dipping to $3.72 on Apr 14, 2026. On average, PRQR is likely to trade around $5.33 in the coming 90 days.
ProQR Therapeutics NV Stock Forecast 2025
Based on our predictive models, ProQR Therapeutics NV (PRQR) is expected to trade between $0.00 and $8.31 throughout 2026. This would result in an average price of $3.74, potentially offering investors a +142.86% return from current levels.
ProQR Therapeutics N.V. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, ProQR Therapeutics N.V. (PRQR) is positioned to show a strong performance in February 2026. The price is predicted to move between $8.13 and $8.31, settling at an average of $8.22. This could translate to a +433.77% gain.
March 2026
Based on current market signals, ProQR Therapeutics N.V. is projected to trend march 2026. We forecast a trading range from $4.31 to $7.98, with a likely average price of $6.77. Investors could expect a potential return of +339.61%.
April 2026
Our predictive algorithms indicate ProQR Therapeutics N.V. stock may see a shift in April 2026. The expected range spans $3.72–$4.95, with an average target of $4.24. This represents a positive outlook and a possible gain of +175.32%.
May 2026
Analyzing established trends, ProQR Therapeutics N.V. looks set to move in May 2026. Projections place the stock between $3.59 and $5.01, averaging around $4.51. This suggests a +192.86% gain from current levels.
June 2026
Market indicators suggest ProQR Therapeutics N.V. could experience notable changes during June 2026. Prices could fluctuate within $2.32 to $3.86, with a midpoint forecast of $3.36. The stock might deliver a +118.18% gain.
July 2026
Forecasting for July 2026, models estimate that ProQR Therapeutics N.V. may undergo key fluctuations. If trends hold, the stock might trade between $2.18 and $3.55, averaging $3.55. This signals a positive trajectory with potential returns around +130.52%.
August 2026
According to our latest forecast models, ProQR Therapeutics N.V. (PRQR) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.91 and $3.28, settling at an average of $3.06. This could translate to a +98.70% gain.
September 2026
Based on current market signals, ProQR Therapeutics N.V. is projected to trend september 2026. We forecast a trading range from $0.19 to $2.44, with a likely average price of $2.59. Investors could expect a potential return of +68.18%.
October 2026
Our predictive algorithms indicate ProQR Therapeutics N.V. stock may see a shift in October 2026. The expected range spans $0.00–$2.59, with an average target of $3.29. This represents a positive outlook and a possible gain of +113.64%.
November 2026
Analyzing established trends, ProQR Therapeutics N.V. looks set to move in November 2026. Projections place the stock between $0.00 and $2.12, averaging around $2.97. This suggests a +92.86% gain from current levels.
December 2026
Market indicators suggest ProQR Therapeutics N.V. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $1.25, with a midpoint forecast of $2.64. The stock might deliver a +71.43% gain.
January 2027
Forecasting for January 2027, models estimate that ProQR Therapeutics N.V. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.54, averaging $1.99. This signals a positive trajectory with potential returns around +29.22%.
February 2027
According to our latest forecast models, ProQR Therapeutics N.V. (PRQR) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $1.64. This could translate to a +6.49% gain.
PRQR's history of dividends and stock splits also plays a role in long-term investor confidence.

